Present status and perspective of laboratory hematology in Japan: On the standardization of blood cell morphology including myelodysplasia: On behalf of the Japanese Society for Laboratory Hematology
Present status and perspective of laboratory hematology in Japan: On the standardization of blood cell morphology including myelodysplasia: On behalf of the Japanese Society for Laboratory Hematology
复制标题
日本实验室血液学的现状和展望：关于包括骨髓增生异常在内的血细胞形态的标准化：代表日本实验室血液学会
DOI：
10.1111/ijlh.12819
复制
发表时间：
2018
影响因子：
3
通讯作者：
Tohyama K.
中科院分区：
文献类型：
--
作者：
Sato A;Kakinuma S;Miyoshi M;Kamiya A;Tsunoda T;Kaneko S;Tsuchiya J;Shimizu T;Takeichi E;Nitta S;Kawai-Kitahata F;Murakawa M;Itsui Y;Nakagawa M;Azuma S;Koshikawa N;Seiki S;Nakauchi H;Asahina Y;Watanabe M.;Tohyama K.
日本实验室血液学会 (JSLH) 成立于 2000 年，由血液学家、医疗技术人员和参与血液实验室检测的公司共同合作成立。 JSLH的宗旨是通过学术会议、定期出版学术期刊、培训和教育（在会议、期刊或网站上）、促进实验室血液学标准化、对实验室血液学专家进行认证，推动实验室血液学的进步和发展。在实验室血液学标准化组织的3个专业委员会中，血细胞形态标准化委员会一直负责处理外周/骨髓血细胞和正常/异常形态的各个项目。另一个独立组织日本特发性骨髓衰竭综合征国家研究小组（BMF）提高了骨髓增生异常综合征（MDS）的重要性，并一直在进行MDS的前瞻性登记、集中审查和随访研究。该课题组最近提出了MDS诊断准确性的分级系统，并在专门的彩色图谱中展示了MDS形态学诊断的详细流程，并附有各种不典型增生的典型照片。 JSLH还批准了MDS诊断准确性分级系统，并将该标准化诊断系统纳入实验室血液学专家认证的教育项目中，旨在在全国范围内扩大骨髓增生异常的形态学评估。通过 JSLH 的活动，预计日本将在血细胞形态标准化方面取得进一步重大进展。
The Japanese Society for Laboratory Hematology (JSLH) was launched in 2000 and has been developed by a mutual collaboration of hematologists, medical technologists, and the companies involved in hematological laboratory testing. The aim of JSLH is the progress and development of laboratory hematology by academic conferences, periodic publication of academic journal, training and education (in the meeting, the journal, or the website), promotion of the standardization of laboratory hematology, and certification of the laboratory hematology specialists. Among 3 specialized committees organized for the standardization of laboratory hematology, the standardization committee on blood cell morphology has been dealing with the various projects on peripheral/bone marrow blood cells and normal/abnormal morphology. Another independent organization, the Japanese National Research Group on idiopathic bone marrow failure syndromes (BMF), has raised the importance of the dysplasia of myelodysplastic syndromes (MDS) and has been conducting the prospective registration, central review, and follow‐up study of MDS. This group recently proposed the grading system for diagnostic accuracy of MDS, and the detailed procedure of morphological diagnosis of MDS is presented in the specialized color atlas with typical photographs of various dysplasia. JSLH has also approved the grading system for diagnostic accuracy of MDS and adopted this standardized diagnostic system to the educational item for certification of the laboratory hematology specialists, aiming at a nationwidely expanding morphological evaluation of myelodysplasia. Further and significant progress in the standardization of blood cell morphology will be expected in Japan through the activity of JSLH.